Company / Goodwill
SELLAS Life Sciences Group, Inc. Goodwill History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$1.9M
FY2024
5-year range
$1.9M / $1.9M
FY2020-FY2024
Trend
+0.0%
vs FY2023
Sector context
#69 of 74
Health Care
What the data says
Among 74 Health Care companies, SELLAS Life Sciences Group, Inc. is in the bottom 7% for goodwill.
Based on SEC 10-K filings.
$2M in FY2024 with a 5-year CAGR of +0.0%.
Remained stable around $2M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 74This company $1.9M Sector average $4.0B
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.0%, indicating consistent growth.
- In FY2024, goodwill increased 0.0% year-over-year.
- Ranks #69 out of 74 companies in the Health Care sector.
- Peak goodwill was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.9M | +0.0% |
| FY2023 | $1.9M | +0.0% |
| FY2022 | $1.9M | +0.0% |
| FY2021 | $1.9M | +0.0% |
| FY2020 | $1.9M | +0.0% |
| FY2019 | $1.9M | +0.0% |
| FY2018 | $1.9M | +0.0% |
| FY2017 | $1.9M | -67.5% |
| FY2016 | $5.9M | +0.0% |
| FY2015 | $5.9M | +0.0% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026